Projects per year
Abstract
The introduction of drug eluting stents (DES) for the treatment of coronary heart disease has significantly reduced in-stent restenosis, however the use of cytostatic agents causes delayed re-endothelialisation of the target vessel. Here we describe the drug release profiles for rapamycin incorporated into a novel acrylic-based polymer designed to promote vascular re-endothelialisation. Understanding drug release from the surface of DES is integral to the stent development process. It is useful for testing the reliability and reproducibility of coatings and for providing insight into mechanisms of drug release.
Original language | English |
---|---|
Publication status | Published - 30 Aug 2015 |
Event | 27th European Conference on Biomaterials - ICE Krakow Congress Centre, Krakow, Poland Duration: 30 Aug 2015 → 3 Sept 2015 |
Conference
Conference | 27th European Conference on Biomaterials |
---|---|
Abbreviated title | ESB 2015 |
Country/Territory | Poland |
City | Krakow |
Period | 30/08/15 → 3/09/15 |
Keywords
- drug delivery
- drug release
- coronary stent coating
- drug eluting stents
- DES
Fingerprint
Dive into the research topics of 'Assessment of drug incorporation and release from a novel coronary stent coating'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Optimal designs of drug eluting stents
McKee, S. (Principal Investigator), Ainsworth, M. (Co-investigator), Wadsworth, R. (Co-investigator) & McCormick, C. (Research Co-investigator)
EPSRC (Engineering and Physical Sciences Research Council)
1/04/12 → 30/09/15
Project: Research